Review Article | Open Access
Daniel Boison, Cynthia Ayefoumi Adinortey, Godwin Kweku Babanyinah, Olga Quasie, Rosemary Agbeko, Gilbert Kofi Wiabo-Asabil, Michael Buenor Adinortey, "Costus afer: A Systematic Review of Evidence-Based Data in support of Its Medicinal Relevance", Scientifica, vol. 2019, Article ID 3732687, 10 pages, 2019. https://doi.org/10.1155/2019/3732687
Costus afer: A Systematic Review of Evidence-Based Data in support of Its Medicinal Relevance
Costus afer (C. afer) is a plant commonly known as ginger lily, spiral ginger, or bush cane. It is reportedly used in traditional medicine practice (TMP) to treat and manage many ailments including diabetes mellitus, stomach ache, arthritis, inflammation, and gout. These purported ethnomedicinal uses have triggered many research studies on the plant to amass scientific evidence. However, these research reports are scattered, and thus, this systematic review seeks to provide a comprehensive update on it covering its traditional uses, phytochemical and nutritional constituents, pharmacological activities, and toxicological effects. An online search was done using search engines such as Google Scholar, PubMed, and ScienceDirect from the period 1970 to 2019. The online search included the use of keywords, “Costus afer Ker-Gawl” or “Costus afer.” The search revealed that the stem and leaves of the plant contain substantial amounts of micronutrients and macronutrients. The leaves, stem, rhizomes, and roots of C. afer contain several steroidal sapogenins, aferosides, dioscin, and paryphyllin C and flavonoid glycoside kaempferol-3-O-α-L-rhamnopyranoside. Experimental studies on various parts of the plant showed bioactivities such as antihyperglycemic, hepatocellular protection, cardioprotection, nephroprotection, testicular protection, CNS depressant, analgesic, antiarthritis, antibacterial, and antioxidant. Based on these evident data, it is concluded that the plant could be used as an alternative and complementary therapy for many oxidative stress-related diseases, provided further scientific studies on the toxicological and pharmacological aspects are carried out.
The use of herbal medicine to manage or cure diseases dates back to the Stone Age. There has been an advancement in pharmacological discoveries over the years that has resulted in the production of many synthetic drugs. This therefore reiterates the worth of ethnomedicinal plants for drug discovery. Costus afer Ker-Gawl (C. afer) with synonyms Costus obliterans Schum, Costus anomocalyx Schum, and Costus insularis Chev. is a rhizomatous herb commonly known as ginger lily or “bush cane” [1–4]. Almost every part of this plant is endowed with medicinal potential in diseases such as malaria, measles, diabetes mellitus, arthritis, and stomach disorders. In West Africa for instance, the succulent stem is chewed to quench thirst and also to treat cough and its accompanying sore throat [5, 6]. Various solvent extracts of the plant leaves, stem, rhizomes, and roots have been studied and reported to contain chemical compounds that could be useful in the alleviation of oxidative stress-related conditions [7–9].
A number of research studies have gone into finding bioactive compounds of plant origin with pharmacological properties to be used in the design of new drugs with lesser side effects. The several medicinal importance of C. afer makes it serve as one of the plants to attract this kind of research. However, information on its bioactivity, safety profile, and active principles is scattered. Implicitly, there is the need to collate these for easy accessibility that could enhance further research. This review therefore tends to provide a comprehensive update on this plant covering the botanical and ecological distribution, phytochemistry, pharmacological actions, and toxicological consequences associated with usage.
2. Search Method
An online literature search was performed in ScienceDirect, PubMed, and Google Scholar databases using keywords “Costus afer Ker-Gawl” or “Costus afer” with a year limit of articles published from January 1970 to October 2019 in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The search approach is illustrated in a flow diagram (Figure 1). The article selection was based on the following inclusion criteria: articles published in English and articles with keywords in the title, abstract, or full text and studies with isolated compounds from the plant. Articles that were retrieved were manually reviewed with the goal of identifying and excluding works that did not fit the inclusion criteria described. Articles with repeated data and duplication by the search engines were also excluded.
3.1. Taxonomy, Ethnic Names, and Ethnopharmacological Importance
Costus afer Ker-Gawl belongs to the domain Eukaryota, kingdom Plantae, and the family Zingiberaceae now known as Costaceae . It is of the genus Costus and species afer . The various ethnic names to which the plant is referred to in certain dialects in West Africa are documented in Table 1. Traditionally, the plant has several medicinal uses, which are summarized in Table 2. The pharmacological significance that is attached to the use of the plant has led to numerous scientific research publications.
3.2. Botanical and Ecological Distribution
Costus afer Ker-Gawl is usually an unbranched tropical plant often seen as a herb with a creeping rhizome. It is a relatively small monocot shrub which is commonly found in humid and monstrous forests and riverside . It is a perennial plant which can grow as tall as 4 m and bears white and yellow flowers [11, 24]. Its inflorescence is a highly compact, terminal, conical spike of about 2.5 cm to 7.5 cm long, sessile; bracts are oblong, convex, 3.5 cm long, densely imbricate, upper ones usually smaller; apex is truncate to rounded, green with purple markings, each subtending two flowers; bracteoles are boat-shaped, 2.5 cm × 1 cm; and keel is thick and ridged, pale green with pink markings and thin pink papery margin . It has simple leaves, which are arranged spirally. The sheath is lobular, closed, and green with purple blotches. The ligule is about 4 to 8 mm long, which is leathery and glabrous. The leaf blade is elliptical to obovate of about 15 cm to 35 cm 3.5 to 9.5 cm with culminate apex . The margin is sparsely hairy with a bisexual and zygomorphic flower. A picture of C. afer leaves is provided in Figure 2.
Costus is pan tropical with about seventy species, of which forty are found in tropical America, twenty-five in West tropical Africa, and five in South-East Asia . In Africa, the plant is found in the forest belt from Senegal to Ethiopia and in the East to Tanzania. In tropical West Africa, it is found in the rain forest and riverbanks of countries including Ghana, Sierra Leone, Senegal, Guinea, Togo, Cameroon, and Nigeria [5, 11].
3.3. Nutritional and Phytochemical Composition of Costus afer
C. afer is used by the local folks, due to its nutritional and medicinal properties. This involves the use of the plant parts such as leaf, stem, and the rhizome in preparation of food [7, 18]. The proximate analysis of different parts of C. afer shows the presence of both macro- and micronutrients [26, 27]. Both the leaves and stem are rich in macronutrients such as carbohydrate, crude protein, fat, ash, moisture, and a good source of fiber. There are also reports of the presence of certain vital nutrients such as vitamins B (1, 2, 3, 6, and 12), E, and C in the leaves . The oil extracted from the plant is made up of 78% saturated fatty acids and 22% unsaturated fatty acids . The phytochemical analysis of the leaves, stem, and the rhizome of this plant in different solvents shows the presence of alkaloids, phenols, saponins, triterpenes, tannins, and glycosides [2, 29, 30]. These phytochemicals and nutrients may justify the nutraceutical use of the plant . Research on the chemical identification and isolation of bioactive compounds from C. afer has been carried out, and this has led to the elucidation of structures from different parts of the plant [21, 31, 32]. For instance, the rhizome is reported to contain steroidal saponins such as diocin, paryphyllin C, aferoside B, and aferoside C. Kaempferol-3-O-R-L-rhamnopyranoside, which is a flavonoid glycoside, has also been identified from the aerial part of the plant . Additional aferoside A  and aferosides B and C  have been isolated from the roots of C. afer. The structures of some compounds reported to be found in C. afer leaves, stem, rhizome, and roots are shown in Figure 3.
3.4. Pharmacological Activities of Costus afer
3.4.1. Pancreatic Protection, Antidiabetic Property, and Hypolipidemic Effect
Diabetes mellitus is a chronic hormonal and metabolic disorder that is characterized by a persistent increase in blood glucose levels. In an alloxan-induced rat model, there was a significant reduction in blood glucose level when C. afer leaf extract at concentrations of 375, 750, and 1125 mg/kg and the control drug (glibenclamide (5 mg/kg)) were orally given . A study by Ezejiofor and colleagues reported in 2014, 2015, and 2017 showed that C. afer leaf and stem extracts are able to reverse histopathological damage of pancreatic β-cells in alloxan-induced diabetes mellitus [34–36]. These reports are consistent with the work by ThankGod et al. , reporting on the evidence of regeneration of islet cell on the administration of C. afer stem extract to streptozotocin-induced rats. According to a report by Ezejiofor and colleagues published in 2015 , oral administration of 750 and 1125 mg/kg of C. afer leaf extract produced a more prominent regeneration and repopulation of islet cells. The same research group in 2017 in a histopathological study of C. afer stem extract on alloxan-induced damaged pancreatic cells noticed an organ protective effect . This therefore indicates that C. afer leaf and stem extracts have pancreatic islet cell protective and regenerative effect that could be explored in managing type I diabetes mellitus.
Other studies have also attempted to elucidate mechanisms through which the C. afer leaf and stem extract may be exhibiting their antihyperglycemic effects. In an in vitro study involving different solvent extracts of C. afer leaf, stem, and rhizome on the activities of alpha-glucosidase and alpha-amylase enzymes, there was a significant inhibition of these enzymes. Ethyl acetate rhizome and methanol leaf extract exhibited the highest inhibitory effect with an IC50 of 0.10 and 5.99 mg/mL, respectively .
Glucose transport in 3T3-L1 adipocytes is a recognized in vitro model that represents a critical experiment for glucose utilization and disposal in mammals. In a study reported by Anaga and colleagues in 2004 , C. afer leaf extract displayed a high capacity to transport glucose at very low concentration (10 μg/ml). When the effect of insulin at a concentration of 340 nM and extract at 10 μg/ml concentration was compared, the extract caused about 96% glucose uptake compared to insulin in 3T3-L1 adipocytes. C. afer is also reported to significantly decrease plasma glucose after 30 to 60 minutes of oral administration than the reference drug tolbutamide.
It is clear that several studies attest to the fact that C. afer acts as an antidiabetic agent via biochemical mechanisms including restitution of pancreatic β-cell function, amelioration of insulin resistance by sensitizing receptors, inhibition of liver gluconeogenesis, enhanced glucose absorption, and inhibition of G-6-Pase, α-amylase, and α-glucosidase activities. The stem and roots are reported to contain several bioactive compounds [21, 32] with diosgenin and aferosides A, B, and C named as the most likely compounds responsible for the antidiabetic properties of C. afer . Diosgenin ameliorates insulin resistance by increasing glucose usage and intracellular glycogen synthesis .
The concentration of lipids such as triacylglyceride (TAG), total cholesterol (TC), very low-density lipoprotein (VLDL), and low-density lipoprotein (LDL) is highly regulated to avoid certain clinical conditions such as steatosis. This condition occurs when there is abnormal retention of lipids within a cell as a result of impairment in the normal synthesis and degradation of fats. Accumulation of these fats is often associated with disorders and diseases such as diabetes mellitus, obesity, and hepatitis C. When the body is unable to control fat regulation, there is the need for extracellular regulation, which includes the use of a natural product such as C. afer. In both carbon tetrachloride-induced model  and streptozotocin-induced diabetic rat model , there was a significant rise in the TAG, TC, and LDL levels in negative control animals. On the administration of C. afer extract, there was a significant improvement in the lipid profile as indicated by lowering serum TAG, TC, and LDL levels to near normal . Results from these studies indicate that C. afer plant leaves could be explored in the management of diabetes mellitus and its complications such as dyslipidemia.
3.4.2. Protective Ability against Kidney, Liver, Heart, Testicle, and Mitochondrial Damage
When the body is exposed to toxins or drugs, it becomes imperative for organs such as the liver and kidney to detoxify such substances. The liver is usually involved in the biotransformation of toxins to less toxic compounds through phase I and II reactions to enhance their elimination by kidneys. In a disease state of the kidney, its detoxifying capacity is impaired. Toxicity of the kidney results in elevated concentrations of sodium and potassium in the serum and enlarged kidney. In cyclosporin-a- (Csa-) induced nephrotoxicity animal model, there is generally a significant elevation of serum K+, Na+, BUN, and creatinine in negative control animals compared to the normal rats. A report published by Ezejiofor et al. indicates that oral administration of aqueous C. afer leaf extract showed a significant dose-dependent reduction of serum BUN and K+ .
In a gentamicin-induced nephrotoxicity model involving oral administration of aqueous C. afer leaf extract, there was a significant decrease in sodium, blood urea level, and serum creatinine level. There was as well a significant decrease in serum potassium concentration, which occurred in a dose-dependent manner. The low and medium dose of aqueous leaf extract of C. afer reversed the deleterious effect of gentamicin on the kidney . The C. afer-treated rats regained their normal kidney morphology with glomeruli and compact tissue appearance while the untreated rat showed the presence of dissolved cells due to necrosis of the nephron and widespread infiltration of inflammatory cells. There was an observed improvement in tissue architecture with visible glomeruli and less cell inflammation when C. afer leaf extract with doses of 375–1125 mg/kg was administered . This depicts the fact that C. afer leaves have nephroprotective property.
Another study reported by Ezejiofor and Orisakwe in 2019 also noticed the ability of C. afer in lead-induced kidney damage model. The study observed a significant reversal in the decreased levels of glutathione peroxidase (GSH-PX), superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase activity (GST) seen in the lead acetate only treated group . This observation shows that C. afer seems to have a nephroprotective effect against lead-induced damage in a male albino rat model.
The role of the liver is so critical that there is a need to protect it from damage. One of the causes of damage to the liver is oxidative stress and its close proximity to the intestines makes it more prone to a wide spectrum of food-borne toxins. The damaging effect of free radicals to the liver is increased during exposure to xenobiotic such as drugs. A defect in the liver leads to the leakage of certain liver enzymes into the blood. These enzymes include alanine aminotransferase, alkaline phosphatase, and aspartate aminotransferase. These enzymes therefore serve as biomarkers for the detection of liver damage in serum. In a study model involving induced liver injury by the oral administration of carbon tetrachloride (CCl4) in rats, there was a significant reduction in serum AST and alkaline phosphatase (ALP) close to the normal at an oral administration of 400 mg/kg of C. afer extract compared to rat fed with 200 mg/kg of the extract . In another study, it was demonstrated that C. afer stem extract possesses the ability to protect against alcohol-induced liver damage in rats , indicating that C. afer has pharmacological activity against alcohol liver cirrhosis.
In a cardiac-induced toxicity with CCl4 (2.5 mL/kg) with olive oil in a ratio of 1 : 1, there is usually formation of CCl3OO radical that causes the peroxidation of polyunsaturated fatty acids associated with the cardiac cell. In a study involving CCl4-induced cardiac toxicity, administration of C. afer leaf extract proved protective . This was depicted by a significant improvement in the lipid profile as indicated by low serum TAG, TC, and LDL levels to near normal.
Lead (Pb) is a multiple organ toxicant and an oxidative stress inducer. The protective effect of aqueous leaf extract of C. afer on Pb-induced testicular damage was evaluated in a study reported by Ezejiofor and Orisakwe in 2019 . The result showed insignificant changes in the weights of epididymis and testes when extract treated Pb group was compared with the normal control. Marked rise was noted in the sperm analysis, blood Pb level, and luteinizing hormone (LH) and a decrease was observed in follicle-stimulating hormone (FSH) with nonsignificant changes in testosterone in the extract treated Pb group compared to the normal control. The outcome according to the researchers depicts the fact that aqueous leaf extract of C. afer may be protective against lead-induced testicular damage.
Cadmium toxicity is generally treated with chelating agents such as dimercaprol mesomercaptosuccinic acid and ethylenediaminetetraacetic acid (EDTA) which are commercially available, and results of many histological studies have shown that the chelating agents are not safe. C. afer, a plant natural agent, was explored in a study to ascertain its potential in protecting against Cd-induced reproductive toxicity in male rats. The results reported in by Atere and Akinloye  are at variance with what Ezejiofor and Orisakwe also reported when they used lead as the toxic agent . The antioxidant role of C. afer plant extract in these pharmacological activities cannot be overemphasized as there are several published reports to substantiate it [2, 7, 9, 25, 40, 43].
Another report by Anyasor and colleagues published in 2017  shows a chemoprotective activity of C. afer against Ca2+-induced mitochondrial membrane permeability transition (MPT). According to the report, both C. afer leaf and stem extracts obtained from different solvents notably inhibited Ca2+-induced mitochondrial MPT when compared with an untreated mitochondrial fraction in the presence of Ca2+ ion [4, 46]. In a study, C. afer hexane leaf extract at a dose of 10–60 μg/ml significantly inhibited Ca2+-induced MPT by 85.66% to 90.45% . This suggests that C. afer contain certain bioactive compounds that chelate calcium ion to help stabilize the membrane, thus inhibiting mitochondrial MPT. This indicates that C. afer leaves could help cure and manage oxidative stress and neurodegenerative diseases such as Alzheimer’s disease.
Almost all the pharmacological effects observed in the chemical-induced organ damage models have been attributed to antioxidant or free radical scavenging potential as demonstrated by Tchamgoue and colleagues . Many studies have demonstrated the in vitro and in vivo antioxidant abilities of C. afer. In an in vivo study on cardiac toxicity, for example, there was a significant reduction in lipid peroxidation, improvement in lipid profile, and increase in antioxidant activity . There was also a decrease in the creatine kinase (CK) and aspartate aminotransferase (AST) levels. Meanwhile, there was an improvement in the activity of superoxide dismutase (SOD), catalase (CAT), and glutathione S-reductase (GSR) which shows that C. afer extract renders cardiac protection against toxicity . In an in vivo nephrotoxicity model, C. afer aqueous leaf extract significantly resulted in an increase in GSH, CAT, SOD, and GST (glutathione S-transferase) activity in rats .
In vitro antioxidant studies on aqueous stem extract of C. afer showed an IC50 value of 92.33 mg/mL for DPPH (diphenylpicrylhydrazyl) radical . The methanol extract of the C. afer leaf showed a DPPH scavenging activity with an IC50 of 157.48 μg/mL . Hexane leaf extract of C. afer is reported to have NO (nitric oxide) and H2O2 (hydrogen peroxide) scavenging activity with an IC50 of 1.77 mg/mL and 0.33 mg/mL, respectively [7, 9, 25]. All these data depict the fact that C. afer plant could be considered in the drug discovery pipeline as a candidate for protective agent against liver, kidney, heart, testicles, and mitochondrial damage.
3.4.3. Analgesic and Anti-Inflammatory Effects
Analgesic is used as a painkiller without blocking any nerve impulse conduction, altering sensory perception nor affecting consciousness. Some of the methods employed in evaluating analgesic property include acetic acid-induced writhing, the tail flick assay, and the tail immersion assay. A study by Ijioma et al.  investigated the antinociceptive property of C. afer ethanol leaf extract and the stem juice in rats, using different rat models—acetic acid, tail flick, and tail immersion assays. The results indicate that both extract and stem juice of C. afer reduced the number of writhes and increased reaction time in the experimental rats exposed to pain stimuli. Another study  involving hexane, ethyl acetate, n-butanol, and aqueous fraction, the hexane fraction of C. afer leaf exhibited the highest antidenaturation of protein, stabilization of HRBC membrane, and antiproteinase activities when compared with other test fractions. The study further identified compounds, which include phytol, coumaran, hexadecanoic acid, octadecatrienoic acid, and cis-vaccenic acid as some key compounds responsible for the anti-inflammatory effects of the plant.
Momoh and colleagues in 2011  had reported that C. afer contain phytochemical substances including alkaloids, flavonoids, tannins, phenols, glycosides, and terpenoids, some of which have been implicated in antinociception. According to Ijioma et al., the possible mechanisms of action of the leaf and stem juice of C. afer include inhibition of the activity of cyclooxygenase-2 (cox-2) and interference with G-protein-mediated signal transduction.
Inflammation can be defined as the body’s attempt at self-protection with the aim of removing harmful stimuli including damaged cells, irritants, or pathogens and begins the healing process. It is one of the first lines of defense the body adapts to localize and destroy invaded microorganisms or neutralize chemical toxins. Earlier reports by Moody and Okwagbe  had hinted that the chloroform and methanol extracts from the aerial parts displayed a noteworthy reduction in carrageenan-induced rat paw edema, while the methanol extract of the rhizome exhibited marked topical anti-inflammatory effect in croton aldehyde-induced mouse ear edema.
In another study involving arthritis-induced rat model, data collected revealed a significant reduction in plasma total bilirubin, total protein, and globulin concentration in rats treated with C. afer hexane leaf fraction compared with negative control . On oral administration of the plant extract, there was a significant reduction of carrageenan-induced rat paw edema as compared with the negative control group. The inhibition of the paw edema was concentration-dependent . In the arthritis-induced rat model, the oral administration of C. afer hexane leaf fraction showed a significant reduction in white blood cells (WBCs), lymphocytes, neutrophils, basophils, eosinophils, monocytes, and blood platelet count compared with the elevated form in the negative control group. This depicts the fact that C. afer leaf possesses immunomodulation activity against proinflammatory mediators. The hexane fraction of the plant is reported to have high antidenaturation effects on protein, stabilization of HRBS membrane, and antiproteinase with IC50 values of 33.36 μg/mL, 33 μg/mL, and 212.77 μg/mL, respectively . Data reported by Anyasor and colleagues in 2014  linked the anti-inflammatory effects to a boost in the antioxidant status in vivo. The in vivo antioxidant study showed that C. afer hexane extract-treated animals had a marked elevation in the levels of GSH, SOD, CAT, and GST activities while the level of MDA was significantly reduced in the plasma, liver, kidney, and brain.
Reports seen in the analgesic and anti-inflammatory experiments seem to provide some evidence to support the traditional use of C. afer extract for the relief of pain and inflammations in the management of arthritis. Implicitly, the plant could be considered as a drug candidate in pain and inflammatory drug development.
3.4.4. CNS Depressant Activity
The use of central nervous depressants such as phenobarbitone decreases the transmission of impulse between the receptor organs and the effector organs mediated by the brain. In mechanism, the phenobarbitone inhibits GABA receptors and further inhibits chloride current through the receptor channels. That is, the glutamate-induced depolarization is inhibited by the phenobarbitone, thereby causing hypnosis . According to Ezejiofor and Igweze, 300 mg/kg has a little effect on the gait at 90 and 120 minutes compared with the control. There was also a slight effect of 800 mg/kg of C. afer extract on the gait at 60, 90, and 120 minutes and on its movement at 120 minutes. However, there was a potentiating effect of the plant extract on the standard drug in a concentration-dependent manner. The combination of phenobarbitone and extract (300 and 800 mg/kg) showed a significant CNS activity . The results reported hints of a need for more research on CNS depressant effects of C. afer.
3.4.5. Antiparasitic and Antibacterial Property
Aedes aegypti is a mosquito, which is known to spread yellow fever, dengue fever, chikungunya, and zika fever. These mosquitoes are commonly noticed in the tropical and subtropical region including Africa. The conventional agents against these mosquitoes are limited and pose adverse effects on both the individual and the environment. One of the routes to reduce the spread of these diseases by these mosquitoes is through drug agents, which have larvicidal activity against larvae of Aedes aegypti. The eggs of A. aegypti were suspended in water and fed with rabbit pellet until the larvae grew to the 4th instar stage. The leaf and stem extract at a concentration range of 0–5 mg/mL was used to assess the larvicidal activity. It was found that the LC50 values (in both leaf and stem extract) were relatively higher in those exposed to the extract for 28 hours than for 48 hours. The same trend was observed for the reported LC90. This indicates that the long exposure (administration of C. afer extract) augments its larvicidal activity. The LC50 was found to be 8.24 ± 1.15 and 9.00 ± 0.2 at 24 hr and 4.06 ± 0.27 and 3.79 ± 0.05 at 48 hr , respectively.
According to Moundipa and colleagues , C. afer has a mortality effect against Entamoeba histolytica which showed an EC50 of 11.43, 11.02, and 191.10 μg/mL for two, four, and six hours, respectively.
The antibacterial activity of the ethanol extract of C. afer has also been reported. The data available indicate that extract possesses moderate inhibitory activity against Staphylococcus aureus compared to the reference drug . According to Ezejiofor et al., leaf extract showed lower inhibition of the Gram-negative organisms (Pseudomonas aeruginosa and Escherichia coli) compared to the reference drug . The data reported in the literature hints of a need for more research on antibacterial properties of C. afer with regard to other pathogenic bacteria.
3.5. Toxicological Effects of Costus afer
Exogenous substances such as xenobiotic usually pose toxicity to some vital organs in the body even though these organs try to get rid of the toxins. Many drugs are taken to cure and manage diseases and disorders and are seen to be effective at its purpose, but one cannot overlook its side effects. In an acute toxicity study with C. afer hexane leaf extract, male rats were orally given 2000 mg/kg of C. afer hexane leaf fraction after overnight fasting. After 24 hours, the rats were observed for clinical signs in fur color, breathing rate, and death. There were however no clinical signs of toxicity nor death, indicating that C. afer leaf extract is safe even at a dosage of 2000 mg/kg bwt [12, 55, 56].
In a subchronic toxicity study, there was a significant reduction of hemoglobin (HB) and total red blood cell (RBC) count, indicating that long-term use of aqueous leaf extract of C. afer could result in anemia. Further studies need to be done to investigate the bioactive compounds in the plant responsible for the decreased in Hb and total RBC count as well as the type of anemia caused . It was also revealed that aqueous leaf extract of the plant triggered an increase in weight of the liver and other clinical chemistry parameters such as ALT, ALP, AST, and TB but not the kidney. The histological study also showed architectural and vacuolar changes in the hepatic cells, which was concentration-dependent. This was more prominent at a dose of 1125 mg/kg. There was no observed detrimental histological effect/defect on the kidney .
In an abortifacient study reported by Anaga et al.  where virgin female rats administered with C. afer leaf extract were allowed to mate with the male rat, expulsion of the fetuses wrapped in the placenta in the 3rd trimester of pregnancy was observed and reported to be 100% in the studied rats.
4. Concluding Remarks
The pharmacological property of the leaf, stem, and rhizome of C. afer compiled in this piece provides some scientific evidence for its use as an antihyperglycemic, hepatoprotective, cardioprotection, nephroprotective, analgesic, anti-inflammation and antioxidant, and other pharmacological activities. All these findings support its use in the management of various diseases, thus demonstrating its wide-ranging clinical relevance. The compilation of information on C. afer plant parts used for the management of many diseases can serve to promote a more rational medicinal use of the plant. It can also offer evidence-based data for clinical development of the medicinal plant. The presence of high proportions of micro- and macronutrients such as carbohydrates and proteins makes it possible for the consideration of the plant as a nutraceutical. This and the evidence of abundance of phytochemicals are suggestive of the reasons why local folks use this plant. However, pregnant women must be cautioned about the use of the plant since it has the tendency to induce abortion in the 3rd trimester. The current search has exposed the inadequacy of information on the pharmacokinetics and pharmacodynamics of C. afer extracts and its isolated compounds; thus, a call for more research in that regard is needed.
Conflicts of Interest
The authors declare that they have no conflicts of interest.
- N. K. ThankGod, C. C. Monago, and F. C. Anacletus, “Antihyperglycemic activity of the aqueous extract of Costus afer stem alone and in combination with metformin,” European Journal of Biotechnology and Bioscience, vol. 1, no. 5, pp. 19–25, 2014.
- T. Okugbo and K. Oriakhi, “A comparative study of in vitro antioxidant activity and phytochemical constituents of methanol extract of aframomum melegueta and Costus afer leaves,” Jordan Journal of Biological Sciences, vol. 8, no. 4, pp. 273–279, 2015.
- M. M. Iwu and B. N. Anyanwu, “Phytotherapeutic profile of Nigerian herbs I: anti-inflammatory and anti-arthritic agents,” Journal of Ethnopharmacology, vol. 6, no. 3, pp. 263–274, 1982.
- G. Anyasor, F. Onajobi, O. Osilesi, and O. Adebawo, “Hexane fraction of Costus afer Ker Gawl leaf inhibited mitochondrial permeability transition, F1F0 ATPase and scavenged nitric oxide and hydrogen peroxide (957.1),” Journal of Investigational Biochemistry, vol. 3, no. 2, p. 79, 2014.
- G. E. Omokhua, “Medicinal and socio-cultural importance of Costus afer (Ker Grawl) in Nigeria,” African Research Review, vol. 5, no. 5, pp. 282–287, 2011.
- A. O. Taiwo and A. A. Bolanle, “The leaf essential oil of Costus afer Ker-Grawl from Nigeria,” Flavour and Fragrance Journal, vol. 18, no. 4, pp. 309–311, 2003.
- G. N. Anyasor, O. Ogunwenmo, O. A. Oyelana, and B. E. Akpofunure, “Phytochemical constituents and antioxidant activities of aqueous and methanol stem extracts of Costus afer Ker Gawl. (Costaceae),” African Journal of Biotechnology, vol. 9, no. 31, pp. 4880–4884, 2010.
- F. Ukpabi Chibueze, N. Agbafor Kingsley, K. Ndukwe Okorie, and N. S. N. Agwu Akuagwu, “Phytochemical composition of Costus afer extract and its alleviation of carbon tetrachloride–Induced hepatic oxidative stress and toxicity,” International Journal of Modern Botany, vol. 2, no. 5, pp. 120–126, 2012.
- G. N. Anyasor, F. Onajobi, O. Osilesi, O. Adebawo, and E. M. Oboutor, “Anti-inflammatory and antioxidant activities of Costus afer Ker Gawl. hexane leaf fraction in arthritic rat models,” Journal of Ethnopharmacology, vol. 155, no. 1, pp. 543–551, 2014.
- H. O. Edeoga and B. E. Okoli, “Anatomy and systematics in the Costus afer-C. lucanusianus complex (Costaceae),” Acta phytotaxonomica et geobotanica, vol. 48, no. 2, pp. 151–158, 1998.
- B. A. Ekpo, D. N. Bala, E. E. Essien, and S. A. Adesanya, “Ethnobotanical survey of akwa ibom state of Nigeria,” Journal of Ethnopharmacology, vol. 115, no. 3, pp. 387–408, 2008.
- S. C. Udem and C. K. Ezeasor, “The acute and subchronic toxicity studies of aqueous leaf and stem bark extract of Costus afer ker (Zingiberaceae) in mice,” Comparative Clinical Pathology, vol. 19, no. 1, pp. 75–80, 2010.
- R. A. Dickson, I. K. Amponsah, K. Annan, and T. C. Fleischer, “Nutritive potential of a polyherbal preparation from some selected Ghanaian herbs,” Journal of Natural Product and Plant Resources, vol. 4, no. 3, pp. 77–81, 2014.
- H. M. Burkill, The Useful Plants of West Tropical Africa, vol. 1, Royal Botanic Gardens, London, UK, 2nd edition, 1985.
- T. Jiofack, C. Fokunang, N. Guedje et al., “Ethnobotanical uses of medicinal plants of two ethnoecological regions of Cameroon,” International Journal of Medicine and Medical Sciences, vol. 2, no. 3, pp. 60–79, 2010.
- E. N. Ndenecho, “Herbalism and resources for the development of ethnopharmacology in Mount Cameroon region,” African Journal of Pharmacy and Pharmacology, vol. 3, no. 3, pp. 78–86, 2009.
- R. A. Ngono Ngane, M. K. Mogtomo, A. T. Tabou et al., “Ethnobotanical survey of some cameroonian plants used for the treatment of viral disease,” African Journal of Plant Science, vol. 5, no. 1, pp. 15–21, 2011.
- G. Aweke, “Costus afer ker gawl. Record from PROTA4U. PROTA (Plant Resources of Tropical Africa/Ressourcesvégétales del’Afrique tropicale),” PROTA Foundation, Wageningen, Netherlands, 2007, http://www.prota4u.org/search.asp.
- A. O. Anaga, C. J. Njoku, E. S. Ekejiuba, M. N. Esiaka, and I. U. Asuzu, “Investigations of the methanolic leaf extract of Costus afer. Ker for pharmacological activities in vitro and in vivo,” Phytomedicine, vol. 11, no. 2-3, pp. 242–248, 2004.
- F. B. Magassouba, A. Diallo, M. Kouyaté et al., “Ethnobotanical survey and antibacterial activity of some plants used in Guinean traditional medicine,” Journal of Ethnopharmacology, vol. 114, no. 1, pp. 44–53, 2007.
- R.-C. Lin, B. Hanquet, and M.-A. Lacaille-Dubois, “Aferoside A, a steroidal saponin from Costus afer,” Phytochemistry, vol. 43, no. 3, pp. 665–668, 1996.
- E. C. Chukwuma, M. O. Soladoye, and R. T. Feyisola, “Traditional medicine and the future of medicinal Plants in Nigeria,” Journal of Medicinal Plants Studies, vol. 3, no. 4, pp. 23–29, 2015.
- A. R. Lebbie and R. P. Guries, “Ethnobotanical value and conservation of sacred groves of the Kpaa Mende in Sierra Leone,” Economic Botany, vol. 49, no. 3, pp. 297–308, 1995.
- H. O. Edeoga and B. E. Okoli, “Apomictic behaviour in Costus afer - C. lucanusianus (Costaceae) complex in Nigeria,” Feddes Repertorium, vol. 107, no. 1-2, pp. 75–82, 1996.
- T. G. Atere, O. A. Akinloye, R. N. Ugbaja, D. A. Ojo, and G. Dealtry, “In vitro antioxidant capacity and free radical scavenging evaluation of standardized extract of Costus afer leaf,” Food Science and Human Wellness, vol. 7, no. 4, pp. 266–272, 2018.
- M. C. Dike, “Proximate and phytochemical compositions of some browse plant species of southeastern Nigeria,” Global Journal of Agricultural Sciences, vol. 8, no. 1, 2009.
- G. Anyasor, F. Onajobi, O. Osilesi, and O. Adebawo, “Proximate composition, mineral content and in vitro antioxidant activity of leaf and stem of Costus afer (Ginger lily),” Journal of Intercultural Ethnopharmacology, vol. 3, no. 3, p. 128, 2014.
- I. P. Ekpe, E. O. Udosen, and D. Amaechi, “Evaluation of some vitamins and macro-nutrients composition of ethanolic extract of tecoma stans and Costus afer leaves,” International Journal of Biochemistry Research & Review, vol. 23, no. 4, pp. 1–5, 2018.
- M. M. Akpan, C. S. Odeomena, C. N. Nwachukwu, and B. Danladi, “Antimicrobial assessment of ethanolic extract of Costus afer leaves,” Asian Journal of Plant Science and Research, vol. 2, no. 3, pp. 335–341, 2012.
- M. Jesus, A. P. Martins, E. Gallardo, and S. Silvestre, “Diosgenin: recent highlights on pharmacology and analytical methodology,” Journal of Analytical Methods in Chemistry, vol. 2016, Article ID 4156293, 16 pages, 2016.
- G. Anyasor, F. Onajobi, O. Osilesi, O. Adebawo, and E. Oboutor, “Chemical constituents in n-butanol fractions of Costus afer ker Gawl leaf and stem,” Journal of Intercultural Ethnopharmacology, vol. 3, no. 2, p. 78, 2014.
- R. C. Lin, M.-A. Lacaille-Dubois, B. Hanquet, M. Correia, and B. Chauffert, “New diosgenin glycosides from Costus afer,” Journal of Natural Products, vol. 60, no. 11, pp. 1165–1169, 1997.
- A. F. Uwah, E. G. Ewere, and J. I. Ndem, “Hypoglycemic and haematologic effects of crude stem juice of Costus afer on alloxaninduced diabetic wistar rats,” American Journal of Ethnomedicine, vol. 2, no. 4, pp. 2348–9502, 2015.
- A. N. Ezejiofor, Z. N. Igweze, N. A. Udowelle, and O. E. Orisakwe, “Histopathological and biochemical assessments of Costus afer stem on alloxan-induced diabetic rats,” Journal of Basic and Clinical Physiology and Pharmacology, vol. 28, no. 4, pp. 383–391, 2017.
- A. N. Ezejiofor, C. N. Orish, and O. E. Orisakwe, “Cytological and biochemical studies during the progression of alloxan-induced diabetes and possible protection of an aqueous leaf extract of Costus afer,” Chinese Journal of Natural Medicines, vol. 12, no. 10, pp. 745–752, 2014.
- A. N. Ezejiofor, C. N. Orish, and O. E. Orisakwe, “Morphological changes in the pancreas and glucose reduction of the aqueous extract of Costus afer leaf on alloxan-induced diabetic rats,” Journal of Basic and Clinical Physiology and Pharmacology, vol. 26, no. 6, pp. 595–601, 2015.
- A. D. Tchamgoue, L. R. Tchokouaha, P. A. Tarkang, J. R. Kuiate, and G. A. Agbor, “Costus afer possesses carbohydrate hydrolyzing enzymes inhibitory activity and antioxidant capacity in vitro,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 987984, 10 pages, 2015.
- U. O. Njoku, O. F. C. Nwodo, and M. O. Ogugofor, “Cardioprotective potential of methanol extract of Costus afer leaf on carbon tetrachloride-induced cardiotoxicity in Albino rats,” Asian Journal of Pharmaceutical Research and Health Care, vol. 9, no. 2, pp. 51–58, 2017.
- I. Ekpe, E. Orok Udosen, D. Amaechi, and B. Yisa, “Impact of ethanolic extract of Tecoma stans and Costus afer leaves on lipid profile status of streptozotocin induced diabetic wistar rats,” International Journal of Sciences, vol. 4, no. 8, pp. 16–20, 2018.
- A. N. Ezejiofor, N. A. Udowelle, and O. E. Orisakwe, “Nephroprotective and antioxidant effect of aqueous leaf extract of Costus afer Ker gawl on cyclosporin-a (Csa) induced nephrotoxicity,” Clinical Phytoscience, vol. 2, no. 1, p. 11, 2017.
- A. N. Ezejiofor, C. N. Orish, and O. E. Orisakwe, “Costus afer ker gawl leaves against gentamicin-induced nephrotoxicity in rats,” Iranian Journal of Kidney Diseases, vol. 8, no. 4, p. 310, 2014.
- A. N. Ezejiofor and O. E. Orisakwe, “Nephroprotective effect of Costus afer on lead induced kidney damage in albino rats,” International Journal of Physiology, Pathophysiology and Pharmacology, vol. 11, no. 2, pp. 36–44, 2019.
- A. Tonkiri, E. S. Essien, and J. O. Akaninwor, “Evaluation of hepatoprotective and in vivo antioxidant activity of the methanolic stem extract of Costus afer (bush cane) in alcohol induced liver cirrhosis in rats,” Journal of Biological and Food Science Research, vol. 3, no. 3, pp. 29–34, 2014.
- A. N. Ezejiofor and O. E. Orisakwe, “The protective effect of Costus afer Ker Gawl aqueous leaf extract on lead-induced reproductive changes in male albino Wistar rats,” JBRA Assisted Reproduction, vol. 23, no. 3, p. 215, 2019.
- T. G. Atere and O. A. Akinloye, “High dose of standardised extract of Costus afer leaves potentiates cadmium reproductive toxicity in Wistar rats,” Andrologia, vol. 51, no. 9, Article ID e13360, 2019.
- G. Anyasor, E. Obukohwo, and O. Adenike, “Bioactive compounds in Costus afer Ker Gawl leaves and stem fractions protect against calcium ion-induced mitochondrial membrane permeability transition,” American Journal of Research in Medical Sciences, vol. 1, no. 1, pp. 21–26, 2017.
- A. D. Tchamgoue, L. R. Tchokouaha, N. Tsabang, P. A. Tarkang, J. R. Kuiate, and G. A. Agbor, “Costus afer protects cardio-, hepato-, and reno-antioxidant status in streptozotocin-intoxicated wistar rats,” BioMed Research International, vol. 2018, Article ID 4907648, 9 pages, 2018.
- S. N. Ijioma, C. O. Nwosu, C. U. Emelike, A. I. Okafor, and A. A. Nwankwo, “Antinociceptive property of Costus afer Ker stem juice and ethanol leaf extract in albino rats,” Comprehensive Journal of Medical Sciences, vol. 2, no. 2, pp. 14–19, 2014.
- G. N. Anyasor, O. Funmilayo, O. Odutola, A. Olugbenga, and E. M. Oboutor, “Evaluation of Costus afer Ker Gawl. in vitro anti-inflammatory activity and its chemical constituents identified using gas chromatography-mass spectrometry analysis,” Journal of Coastal Life Medicine, vol. 3, no. 2, pp. 132–138, 2015.
- S. Momoh, O. W. Yusuf, M. M. Adamu, C. O. C. Agwu, and F. O. Atanu, “Evaluation of the phytochemical composition and hypoglycaemic activity of methanolic leaves extract of Costus afer in albino rats,” British Journal of Pharmaceutical Research, vol. 1, no. 1, pp. 1–8, 2011.
- J. O. Moody and K. E. Okwagbe, “Topical anti-inflammatory activity of Costus afer,” Nigerian Journal of Natural Products and Medicine, vol. 7, no. 1, pp. 46–48, 2003.
- A. N. Ezejiofor and Z. Igweze, “Some biological and CNS properties of the ethanolic extract of Costus afer stem ker gawl (Costaceae),” World Journal of Pharmacy and Pharmaceutical Sciences, vol. 5, no. 12, pp. 337–353, 2016.
- P. F. Moundipa, K. G. M. Flore, C. F. Bilong, and I. Bruchhaus, “In vitro amoebicidal activity of some medicinal plants of the Bamun region (Cameroon),” African Journal of Traditional, Complementary and Alternative Medicines, vol. 2, no. 2, pp. 113–121, 2005.
- A. N Ezejiofor, Z Igweze, and C. N Amadi, “Evaluations of some biological properties of ethanolic leave extract of Costus afer (ker gawl),” IOSR Journal of Pharmacy and Biological Sciences, vol. 12, no. 1, pp. 62–68, 2017.
- A. N. Ezejiofor, C. N. Orish, and O. E. Orisakwe, “Effect of aqueous leaves extract of Costus afer Ker Gawl (Zingiberaceae) on the liver and kidney of male albino Wistar rat,” Ancient Science of Life, vol. 33, no. 1, pp. 4–9, 2013.
- G. N. Anyasor, F. D. Onajobi, O. Osilesi, and O. Adebawo, “Hematological and lipid profile evaluation of a hexane fraction of Costus afer leaves in arthritic rats,” Pharmaceutical Biology, vol. 53, no. 11, pp. 1671–1676, 2015.
Copyright © 2019 Daniel Boison et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.